{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:35:00Z","timestamp":1760621700003},"reference-count":5,"publisher":"American Psychiatric Association Publishing","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2005,12,1]]},"DOI":"10.1176\/appi.ajp.162.12.2392-a","type":"journal-article","created":{"date-parts":[[2005,12,5]],"date-time":"2005-12-05T17:53:20Z","timestamp":1133805200000},"page":"2392-a-2393","source":"Crossref","is-referenced-by-count":9,"title":["Parkinsonism With Intramuscular Ziprasidone"],"prefix":"10.1176","volume":"162","author":[{"given":"LOUAI","family":"BILAL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CARLOINE","family":"TSAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAMES J.","family":"GASPER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. CHARLES","family":"NDLELA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R16212CIHDIEIE","doi-asserted-by":"crossref","unstructured":"Daniel DG, Potkin SG, Reeves KR, Swift RH, Harrigan EP: Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. Psychopharmacology (Berl) 2001; 155:128\u2013134","DOI":"10.1007\/s002130000658"},{"key":"R16212CIHHEJCI","doi-asserted-by":"crossref","unstructured":"Mason MN, Johnson CE, Piasecki M: Ziprasidone-induced acute dystonia (letter). Am J Psychiatry 2005; 162:625\u2013626","DOI":"10.1176\/appi.ajp.162.3.625-a"},{"key":"R16212CIHGJEHG","doi-asserted-by":"crossref","unstructured":"Ramos AE, Shytle RD, Silver AA, Sanberg PR: Ziprasidone-induced oculogyric crisis. J Am Acad Child Adolesc Psychiatry 2003; 42:1013\u20131014","DOI":"10.1097\/01.CHI.0000070257.24125.91"},{"key":"R16212CIHEBFCB","unstructured":"Ananth J, Burgoyne KS, Niz D, Smith M: Tardive dyskinesia in 2 patients treated with ziprasidone. J Psychiatry Neurosci 2004; 29:467\u2013469"},{"key":"R16212CIHDJDBC","doi-asserted-by":"crossref","unstructured":"Daniel DG, Zimbroff DL, Swift RH, Harrigan EP: The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy. Int Clin Psychopharmacol 2004; 19:9\u201315","DOI":"10.1097\/00004850-200401000-00002"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.162.12.2392-a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T20:47:53Z","timestamp":1721854073000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.162.12.2392-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,1]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12,1]]}},"alternative-id":["10.1176\/appi.ajp.162.12.2392-a"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.162.12.2392-a","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,1]]}}}